Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial.

Ching-Yang WuChia-Lin LeeChing-Feng WuJui-Ying FuCheng-Ta YangChi-Tsung WenYun-Hen LiuHui-Ping LiuJason Chia-Hsun Hsieh

Published in: Diagnostics (Basel, Switzerland) (2020)

CTC testing can potentially serve as a tool for minimal residual disease detection in early-staged lung cancer after curative surgery.

Keyphrases